Application of TEE-guided minimally invasive congenital heart disease occlusion
10.13929/j.1672-8475.201810023
- Author:
Yongfeng REN
1
Author Information
1. Dpartment of Ultrasound, Bozhou People's Hospital
- Publication Type:Journal Article
- Keywords:
Echocardiography, transesophageal;
Heart defects, congenital;
Interventional therapy;
Minimally invasive
- From:
Chinese Journal of Interventional Imaging and Therapy
2019;16(8):460-463
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical value of TEE-guided interventional occlusion for treating congenital heart disease (CHD). Methods: Clinical data of 50 CHD patients who underwent TEE-guided minimally invasive closure were analyzed retrospectively. There were 29 cases of ventricular septal defect (VSD), 12 cases of atrial septal defect (ASD), 1 case of ASD combined with VSD and 8 cases of patent ductus arteriosus (PDA). The interventional occlusions were performed through transthoracic approach. Before occlusion, TEE was used to diagnose and observe the heart defect again, while intraoperative TEE was used for real-time monitoring and guiding the wire and sheath aimed to the designated position and occlusion umbrella placement. Postoperative TEE was also performed to evaluate the occlusion effect. Electrocardiogram was used to monitor the arrhythmia and conduction block of patients. Results: Interventional occlusions were successfully performed in 49 cases under the guidance of TEE. Remaining shunts were found in 11 patients with TEE immediately after interventional occlusion. TEE reexamined at 1, 3 and 6 months after operation showed satisfied occluder position in all 49 patients. Neither residual shunt nor valve regurgitation caused by occlusion was found. And there was no arrhythmia and conduction block detected with ECG. The occlusion of VSD failed in 1 patient. Conclusion: TEE is a safe, effective, minimally invasive, radiation-free and needing no contrast media method for guiding transthoracic interventional occlusion for treatment of CHD, worthy of clinical popularization and application.
